
Doudna’s AI-designed tiny nucleases promise on-demand gene editing
Nobel laureate Jennifer Doudna and colleagues report an AI-driven platform for designing non-natural nucleases, producing a tiny TnpB enzyme capable of binding and cutting DNA in human, plant, and bacterial cells. By using an inverse protein-model to tailor sequences to predefined backbones, the team envisions on-demand enzyme design with potential medical and agricultural applications and notes possible IP implications as the field advances.






